SCHEMBL7739014

SCHEMBL7739014

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1cccnc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.63
FLT1 P17948 1/20 0.63
FLT4 P35916 1/20 0.63
PIK3CA P42336 3/20 0.43
PIK3CG P48736 3/20 0.43
HDAC1 Q13547 2/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
KDM4E B2RXH2 1/20 0.43
APOBEC3A P31941 1/20 0.43
GFER P55789 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
CYP1A2 P05177 1/20 0.41
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7979617 0.94 KDR (0.55) KDRFLT1FLT4PIK3CAPIK3CG
SCHEMBL7744663 0.90 KDR (0.76) KDRFLT1FLT4PIK3CGHDAC1
SCHEMBL7980820 0.90 KDR (0.66) KDRFLT1FLT4PIK3CAPIK3CG
SCHEMBL7983597 0.90 KDR (0.65) KDRFLT1FLT4PIK3CAPIK3CG
SCHEMBL7744167 0.89 HDAC1 (0.53) KDRFLT1FLT4HDAC1KDM4E
SCHEMBL7983232 0.88 KDR (0.57) KDRFLT1FLT4PIK3CAPIK3CG
SCHEMBL7739065 0.87 KDR (0.50) KDRFLT1FLT4KDM4EGFER
SCHEMBL7744651 0.86 HPGD (0.51) KDRFLT1FLT4KDM4ECYP1A2
SCHEMBL7739087 0.85 KDR (0.69) KDRFLT1FLT4HDAC1KDM4E
SCHEMBL7982616 0.84 KDR (0.56) KDRFLT1FLT4PIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed